Ciprofloxacin therapy of experimental endocarditis caused by methicillin-susceptible or methicillin-resistant Staphylococcus aureus (Q28361123)

scientific article

Language	Label	Description	Also known as
English	Ciprofloxacin therapy of experimental endocarditis caused by methicillin-susceptible or methicillin-resistant Staphylococcus aureus	scientific article

Statements

instance of

scholarly article

0 references

title

Ciprofloxacin therapy of experimental endocarditis caused by methicillin-susceptible or methicillin-resistant Staphylococcus aureus (English)

0 references

main subject

methicillin-resistant Staphylococcus aureus

0 references

Staphylococcus aureus

1 reference

M Fernandez-Guerrero

1

0 references

M Rouse

series ordinal

2

0 references

N Henry

series ordinal

3

0 references

W Wilson

series ordinal

4

0 references

language of work or name

English

0 references

publication date

May 1988

0 references

published in

Antimicrobial Agents and Chemotherapy

0 references

volume

32

0 references

issue

5

0 references

page(s)

747-51

0 references

cites work

Ciprofloxacin, a quinolone carboxylic acid compound active against aerobic and anaerobic bacteria

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=172264

retrieved

29 September 2017

In vitro activity of ciprofloxacin (Bay o 9867)

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=172264

retrieved

29 September 2017

Experimental endocarditis I. Staphylococcal endocarditis in rabbits resulting from placement of a polyethylene catheter in the right side of the heart

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=172264

retrieved

29 September 2017

Ciprofloxacin versus vancomycin in the therapy of experimental methicillin-resistant Staphylococcus aureus endocarditis

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=172264

retrieved

29 September 2017

Efficacy of ciprofloxacin for experimental endocarditis caused by methicillin-susceptible or -resistant strains of Staphylococcus aureus

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=172264

retrieved

29 September 2017

Community-acquired methicillin-resistant Staphylococcus aureus endocarditis in the Detroit Medical Center

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=172264

retrieved

20 June 2018

Staphylococcal bacteremia and endocarditis: state of the art.

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=172264

retrieved

20 June 2018

In vitro activity of ciprofloxacin, a new carboxyquinoline antimicrobial agent

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=172264

retrieved

20 June 2018

Pharmacokinetics and tissue penetration of ciprofloxacin

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=172264

retrieved

20 June 2018

In-vitro studies with ciprofloxacin, a new 4-quinolone compound.

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=172264

retrieved

20 June 2018

The in-vitro activity of ciprofloxacin compared with that of norfloxacin and nalidixic acid.

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=172264

retrieved

20 June 2018

Efficacy of vancomycin plus rifampin in experimental aortic-valve endocarditis due to methicillin-resistant Staphylococcus aureus: in vitro-in vivo correlations

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=172264

retrieved

20 June 2018

The in-vitro activity of some antimicrobial agents against methicillin-resistant Staphylococcus aureus

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=172264

retrieved

20 June 2018

Antimicrobial Therapy of Experimental Endocarditis Caused by Staphylococcus aureus

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=172264

retrieved

20 June 2018

Single or Combination Therapy of Staphylococcal Endocarditis in Intravenous Drug Abusers

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=172264

retrieved

20 June 2018

Staphylococcus aureus endocarditis: clinical manifestations in addicts and nonaddicts.

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=172264

retrieved

27 November 2018

Combination antimicrobial therapy for Staphylococcus aureus endocarditis in patients addicted to parenteral drugs and in nonaddicts: A prospective study

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=172264

retrieved

27 November 2018

Vancomycin therapy for methicillin-resistant Staphylococcus aureus

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/3164989

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Imipenem therapy of experimental Staphylococcus aureus and Streptococcus faecalis endocarditis

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/3164989

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Efficacy of imipenem/cilastatin in endocarditis

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/3164989

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

0 references

0 references

0 references

Ciprofloxacin therapy of experimental endocarditis caused by methicillin-susceptible or methicillin-resistant Staphylococcus aureus (Q28361123)

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Navigation menu

Ciprofloxacin therapy of experimental endocarditis caused by methicillin-susceptible or methicillin-resistant Staphylococcus aureus (Q28361123)

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Navigation menu

Search